Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation

被引:0
|
作者
Hui Miao
Elisabeth Burnett
Michael Kinch
Erin Simon
Bingcheng Wang
机构
[1] Rammelkamp Center for Research,Department of Basic Medical Sciences
[2] MetroHealth Campus,undefined
[3] Case Western Reserve University School of Medicine,undefined
[4] Purdue University Cancer Center,undefined
来源
Nature Cell Biology | 2000年 / 2卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Interactions between receptor tyrosine kinases of the Eph family and their ligands, ephrins, are implicated in establishment of organ boundaries and repulsive guidance of cell migration during development, but the mechanisms by which this is achieved are unclear. Here we show that activation of endogenous EphA2 kinase induces an inactive conformation of integrins and inhibits cell spreading, migration and integrin-mediated adhesion. Moreover, EphA2 is constitutively associated with focal-adhesion kinase (FAK) in resting cells. Within one minute after stimulation of EphA2 with its ligand, ephrin-A1, the protein tyrosine phosphatase SHP2 is recruited to EphA2; this is followed by dephosphorylation of FAK and paxillin, and dissociation of the FAK–EphA2 complex. We conclude that Eph kinases mediate some of their functions by negatively regulating integrins and FAK.
引用
收藏
页码:62 / 69
页数:7
相关论文
共 50 条
  • [41] (+)-Catechin inhibits intestinal tumor formation and suppresses focal adhesion kinase activation in the Min/+ mouse
    Weyant, MJ
    Carothers, AM
    Dannenberg, AJ
    Bertagnolli, MM
    CANCER RESEARCH, 2001, 61 (01) : 118 - 125
  • [42] The role of the focal adhesion kinase PYK2 in platelet activation
    Canobbio, I
    Cipolla, L.
    Consonni, A.
    Guidetti, G.
    Momi, S.
    Oliviero, B.
    Falasca, M.
    Okigaki, M.
    Balduini, C.
    Gresele, P.
    Torti, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 737 - 737
  • [43] Receptor tyrosine kinase EPHA2 is required for epidermal barrier homeostasis
    Shi, B.
    Selph, T.
    Russell, K.
    Mahi, T.
    Khan, E.
    Martinez, I.
    Sinchi-Paucar, G.
    Liu, M.
    Peng, H.
    White, B. E. Perez
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S133 - S133
  • [44] Epithelial Cell Kinase (ECK/EphA2) regulation in breast cancer
    Zantek, ND
    Fedor-Chaiken, M
    Brackenbury, R
    Kinch, MS
    MOLECULAR BIOLOGY OF THE CELL, 1998, 9 : 134A - 134A
  • [45] The role of the focal adhesion kinase Pyk2 in platelet activation
    Cipolla, L.
    Canobbio, I.
    Consonni, A.
    Guidetti, G.
    Momi, S.
    Oliviero, B.
    Falasca, M.
    Okigaki, M.
    Balduini, C.
    Gresele, P.
    Torti, M.
    FEBS JOURNAL, 2011, 278 : 355 - 355
  • [46] Estrogen and Myc negatively regulate expression of the EphA2 tyrosine kinase
    Zelinski, DP
    Zantek, ND
    Walker-Daniels, J
    Peters, MA
    Taparowsky, EJ
    Kinch, MS
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2002, 85 (04) : 714 - 720
  • [47] Loss of EphA2 receptor tyrosine kinase reduces ApcMin/+ tumorigenesis
    Bogan, Christina
    Chen, Jin
    O'Sullivan, M. Gerard
    Cormier, Robert T.
    INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (06) : 1366 - 1371
  • [48] Role of EPHA2 receptor tyrosine kinase in ischemic stroke outcome
    Thundyil, J.
    Manzanero, S.
    Pavlovski, D.
    Coulthard, M. G.
    Arumugam, T., V
    INTERNATIONAL JOURNAL OF STROKE, 2012, 7 : 12 - 12
  • [49] Regulation of antitumor immune response by EphA2 receptor tyrosine kinase
    Shi, Roger Xiaojun
    Lingerak, Ryan
    Kim, So-Yeon
    Wang, Wei
    Sossey-Alaoui, Khalid
    Wang, Bingcheng
    CANCER RESEARCH, 2023, 83 (07)
  • [50] EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics
    Ireton, RC
    Chen, J
    CURRENT CANCER DRUG TARGETS, 2005, 5 (03) : 149 - 157